Cover Image

Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study

ObjectivesBlinatumomab was shown to be safe and effective for consolidation therapy in B-cell acute lymphoblastic leukemia (B-ALL). This study aimed to investigate the effectiveness and safety of blinatumomab in pediatric B-ALL patients in a real-world setting.MethodsThis was a retrospective, observ...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Wu (Author), Yanming Li (Author), Jia Fan (Author), Peijing Qi (Author), Wei Lin (Author), Jie Yang (Author), Huiqing Liu (Author), Xiaoling Wang (Author), Huyong Zheng (Author), Tianyou Wang (Author), Ruidong Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum: Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
by: Ying Wu, et al.
Published: (2022)

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
by: Lee KJ, et al.
Published: (2016)

Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia
by: Le Jeune C, et al.
Published: (2016)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
by: Jiao Xie, et al.
Published: (2023)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
by: Portell CA, et al.
Published: (2013)

Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory setting
by: Alexander Russell-Smith, et al.
Published: (2023)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
by: Maria Maddalena Marrapodi, et al.
Published: (2022)

Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
by: Sandrine Niyongere, et al.
Published: (2020)

Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia
by: Yamini K. Kathari, et al.
Published: (2024)

Efficacy and safety of blinatumomab in children with relapsed/refractory B cell acute lymphoblastic leukemia: A systematic review and meta-analysis
by: Bin Chen, et al.
Published: (2023)

T-lineage acute lymphoblastic leukemia and parvovirus infection in a child with neurofibromastosis-1
by: Pallavi Agarwal, et al.
Published: (2013)

Blinatumomab-associated vasculitis
by: MeiQi May Liau, MBChB, MRCP (UK), et al.
Published: (2017)

Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report
by: Suleimen Zhumatayev, et al.
Published: (2024)

Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia
by: Xue Tang, et al.
Published: (2024)

Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
by: Suliman A. Alsagaby
Published: (2019)

Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab
by: Krasimira A. Rozenova, et al.
Published: (2023)

Use of blinatumomab and CAR T-cell therapy in children with relapsed/refractory leukemia: A case series study
by: Songmi Wang, et al.
Published: (2023)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
by: te Kronnie Geertruy, et al.
Published: (2009)

CD19-negative B-lineage acute lymphoblastic leukemia: A diagnostic and therapeutic challenge
by: Shashi Bansal, et al.
Published: (2017)

Cost-effectiveness analysis of dasatinib versus imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia patients in China
by: Wang Cao, et al.
Published: (2022)

Real world data on outcomes children with relapsed acute lymphoblastic leukemia over two decades
by: R.D. Suresh, et al.
Published: (2022)

Dual intra- and extracranial lymphoblastic chloromas in relapsed Pediatric Acute Lymphoblastic Leukemia
by: Kainaat Javed, et al.
Published: (2022)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
by: Shang Mengxuan, et al.
Published: (2022)

Early experience with blinatumomab in B-cell precursor (BCP) acute lymphoblastic leukaemia (ALL) at the Tata Medical Center (TMC), Kolkata
by: Debjani Ghosh, et al.
Published: (2022)

Evaluation of minimal residual disease by flowcytometry and its clinicopathological correlation in B-lineage acute lymphoblastic leukemia in a tertiary care centre
by: Himanshu Dhanda, et al.
Published: (2022)

Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)
by: Yannan Jia, et al.
Published: (2022)

Myosin 1g as a high-risk biomarker in a pediatric patient with lineage switch from acute lymphoblastic leukemia to myeloid phenotype
by: Janeth E. Araujo-Cárdenas, et al.
Published: (2023)

Acute myeloid leukemia following a primary mediastinal germ cell tumor
by: Huimin Hong, et al.
Published: (2020)

Leukemia cutis: An unusual presentation of acute lymphoblastic leukemia in a child
by: Xia Jiang, et al.
Published: (2015)

Treatment of acute lymphoblastic leukemia with protocol Hongkong-Indonesia Acute Lymphoblastic Leukemia 97
by: Johannes Bondan Lukito
Published: (2007)

Acute Lymphoblastic Leukemia in Children
by: Dhanu Ganesh Rao, et al.
Published: (2013)

Acute Lymphoblastic Leukemia and Seizures
by: J Gordon Millichap
Published: (1995)

Acute lymphoblastic leukemia in adults
by: Josep-Maria Ribera
Published: (2011)

Longitudinal changes in body mass index, height, and weight in children with acute myeloid leukemia
by: Xiaojia Wen, et al.
Published: (2024)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022)

Expression pattern of CD179 in b-cell acute lymphoblastic leukemia (B-All): A potential utility for lineage assignment and B-ALL MRD monitoring
by: Tembhare Prashant, et al.
Published: (2022)

An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemia
by: Nikhil Patkar, et al.
Published: (2017)

Health utility of children with acute lymphoblastic leukemia in China
by: Wei Wang, et al.
Published: (2023)

CNS complications during treatment of acute lymphoblastic leukemia/lymphoblastic lymphoma
by: Piali Mandal, et al.
Published: (2016)

Novel Aspects in Acute Lymphoblastic Leukemia
Published: (2011)